Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • soleulloa
    Member
    • Aug 2011
    • 34

    #1

    46% reads >Q30 in R2... Why? 😔

    Hi all,

    I've used a MiSeq 500 cycles v2 and 10 pM of my libraries pool + phiX 10%.
    Everything was ok but at cycle 491 the run was stopped (I don't know why).
    I was looking for some paramethers and that is the information:
    1249 mm/k2
    R1: 88.16% cluster PF, 85.13% >Q30
    R2: 88.16% cluster PF, 46.22% >Q30

    Why the quality was so low in R2 sequences? It never ocurrs before ☹️

    Thank you!!!
    Soledad
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    Take a look at this helpful tech note from Illumina about optimizing cluster densities for various sequencing chemistry/platforms.

    Your run is at least borderline over clustered for a V2 run. Once you go past the sweet spot of cluster density for a specific version of chemistry, the cluster density number does not actually reflect reality. If you look at the images from the 485 cycles on you should get an idea of why the run failed. If the images look ok then you should contact Illumina tech support since the run may have suffered a hardware failure.
    Last edited by GenoMax; 05-07-2017, 03:38 PM.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
      by SEQadmin2




      NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
      Today, 06:46 AM
    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-28-2026, 09:57 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-28-2026, 09:51 AM
    0 responses
    15 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    68 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    48 views
    0 reactions
    Last Post SEQadmin2  
    Working...